Prescott Group Capital Management L.L.C. Reduces Stock Position in Medifast Inc $MED

Prescott Group Capital Management L.L.C. trimmed its stake in shares of Medifast Inc (NYSE:MED) by 27.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 79,969 shares of the specialty retailer’s stock after selling 30,031 shares during the period. Prescott Group Capital Management L.L.C.’s holdings in Medifast were worth $1,124,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of MED. Charles Schwab Investment Management Inc. grew its holdings in shares of Medifast by 132.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer’s stock worth $3,580,000 after acquiring an additional 151,434 shares during the period. Acadian Asset Management LLC boosted its position in Medifast by 41.5% during the first quarter. Acadian Asset Management LLC now owns 385,723 shares of the specialty retailer’s stock worth $5,193,000 after purchasing an additional 113,111 shares in the last quarter. Nuveen LLC acquired a new stake in Medifast in the first quarter valued at $407,000. AQR Capital Management LLC grew its holdings in Medifast by 14.5% in the first quarter. AQR Capital Management LLC now owns 199,750 shares of the specialty retailer’s stock valued at $2,693,000 after purchasing an additional 25,366 shares during the last quarter. Finally, Allianz Asset Management GmbH purchased a new position in shares of Medifast in the second quarter valued at $307,000. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MED. Weiss Ratings reiterated a “sell (d)” rating on shares of Medifast in a research report on Wednesday, October 8th. Wall Street Zen downgraded shares of Medifast from a “hold” rating to a “sell” rating in a report on Saturday. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $16.50.

Medifast Stock Up 1.3%

MED opened at $11.95 on Friday. The firm has a market cap of $131.34 million, a P/E ratio of 37.34 and a beta of 0.82. The business’s fifty day simple moving average is $13.35 and its 200 day simple moving average is $13.53. Medifast Inc has a 52 week low of $11.25 and a 52 week high of $21.98.

Medifast (NYSE:MED) last released its earnings results on Monday, November 3rd. The specialty retailer reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.20). Medifast had a net margin of 0.76% and a return on equity of 2.00%. The firm had revenue of $89.41 million during the quarter, compared to analysts’ expectations of $84.10 million. Medifast has set its Q4 2025 guidance at -1.250–0.70 EPS. As a group, equities analysts expect that Medifast Inc will post 0.51 EPS for the current fiscal year.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.